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Abstract
Soluble proteins must protect their structural integrity from water attack by wrapping interactions which imply the
clustering of nonpolar residues around the backbone hydrogen bonds. Thus, poorly wrapped hydrogen bonds constitute
defects which have been identified as promoters of protein associations since they favor the removal of hydrating
molecules. More specifically, a recent study of our group has shown that wrapping interactions allow the successful
identification of protein binding hot spots. Additionally, we have also shown that drugs disruptive of protein-protein
interfaces tend to mimic the wrapping behavior of the protein they replace. Within this context, in this work we study
wrapping three body interactions related to the oncogenic Y220C mutation of the tumor suppressor protein p53. Our
computational results rationalize the oncogenic nature of the Y220C mutation, explain the binding of a drug-like molecule
already designed to restore the function of p53 and provide clues to help improve this function-rescue strategy and to
apply in other drug design or re-engineering techniques.
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Introduction
The tumor suppressor protein p53 participates in most of the
cases of human cancer and is mutated approximately in half of
them [1]. In turn, in almost one third of such mutations the
activity loss is simply a consequence of a lowering in the melting
temperature of the core DNA-binding domain of p53 [2–4] that
leads to a quickly denaturation in the cell [5] (in fact, the wild-type
p53 molecule, that is, the protein without mutations, has very low
stability itself [1–7]). The Y220C mutation, a mutation that
significantly lowers the thermodynamic stability of the protein, is
one of the most frequent oncogenic mutations in p53. The
mutation site, located at the protein’s surface, is distant from the
DNA binding site of p53 and does not alter the overall structure of
such region [6]. Interestingly, such mutation of a tyrosine to
a cysteine promotes the formation of a potentially druggable cavity
at the mutation site. Thus, the binding of a small molecule at this
cavity could stabilize the mutant protein without affecting the
function of p53 and also leaving aside wild-type p53 molecules.
This insight has been exploited by the group of Alan Fersht in
a series of beautiful papers [2–7]. Such group discovered a drug-
like molecule called PhiKan083, a carbazole derivative that binds
to the mutational cavity of p53-Y220C [7], with moderate affinity
(Kd around 150 mM), raising the melting temperature and slowing
down the rate of denaturation of p53-Y220C. Additionally,
fragment screening and isopropanol solvation studies were
conducted in order to map the different interaction sites or ‘‘hot
spots’’ of such mutational cavity [2] in order to provide a blueprint
for the design of molecules that bind to p53-Y220C with drug-like
(submicromolar) affinity.
In turn, the introduction of the wrapping concept by Prof. Ariel
Ferna´ndez has thrown a new light onto the protein stability and
protein binding fields [8–16]. To prevail in water environments,
soluble proteins must protect their backbone hydrogen bonds
(HBs) from the disruptive effect of water attack by clustering
nonpolar residues around them [8–16]. This exclusion of
surrounding water, or wrapping effect, also enhances the
electrostatic contribution by modulating the local dielectric (de-
screening the partial charges) and thus stabilizes the HB. Thus,
underwrapped interactions, called dehydrons, represent thermo-
dynamically unstable, vulnerable sites [8,16] and the level of
underwrapping has been shown to correlate with the degree of
structural disorder [13] (in fact, the most extreme case is
represented by the prion proteins which, being the worst wrapped
proteins in the Protein Data Bank, are so thermodynamically
unstable in monomeric form in solution that they aggregate to
form amyloids [8]; also among the worst wrapped proteins we can
find the toxin proteins, whose dehydrons-rich structure can only
be sustained by the establishment of disulfide bonds [8]). A main
notion that derives from this picture is that dehydrons are adhesive
[8,9], hence promoters of molecular associations because their
inherent stability increases upon approach of additional nonpolar
groups. Thus, dehydrons constitute key motifs that signal protein
binding sites. Under this scenario, the integrity of the interface of
a biomolecular complex (when a protein binds to another protein
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or to a small-molecule ligand) becomes extremely reliant on
intermolecular cooperativity based on three-body correlations [8–
16]: a third nonpolar body protects an electrostatic interaction
pairing the other two and not all three bodies belong to the same
molecule. Thus, wrapper (nonpolar) groups become relevant for
binding interactions when an interfacial hydrogen bond relies on
them in order to remain over a critical wrapping value essential on
stability terms. Such a decomposition of the complex interface into
a web of three-body cooperative interactions enabled us to
successfully predict the hot spots reported by alanine-scanning
experimental studies for a set of protein-protein complexes [15].
Additional support to this methodology comes from our recent
finding that drugs disruptive of protein-protein interfaces tend to
mimic the wrapping behavior of the protein they are meant to
replace [16]. Such wrapping concept is precisely the kind of
knowledge we exploit in the present study.
Within the above-expounded context, the aim of the present
paper is two-fold. In the first place, we shall study the impact
produced by the oncogenic Y220C mutations in terms of
wrapping. We shall show that the tyrosine to cysteine mutation
significantly lowers the wrapping content at the mutation site.
Most notably, the mutation promotes the creation of a dehydron
(the hydrogen bond between cysteine 220 and threonine 155) that
was not present in the wild-type molecule (the corresponding
hydrogen bond between tyrosine 220 and threonine 155 was well
wrapped in the wild-type molecule). This dehydron is also vicinal
to another dehydron preexistent in the wild-type molecule and
whose wrapping content is further diminished by the mutation.
Since dehydrons imply local instabilities [8,10] and are correlated
with structural disorder [12], our study allows for a rationalization
of the oncogenic nature of the mutation. Indeed, our dynamical
studies will show that the oncogenic mutation loosens the HB with
THR 155, which breaks and reforms in the course of time, thus
promoting a local structural vulnerability/destabilization. Such
a wrapping decrease and the dehydron creation also explain the
druggability of the mutation site, eager to receive additional
stabilization by means of intermolecular wrapping. In fact, we
shall see that both the PhiKan083 [7] molecule and some drug-like
fragments experimentally studied [2] do in fact provide wrapping
to this region. Particularly, the binding is shown to restore the
wrapping content of the hydrogen bond between tyrosine 220 and
threonine 155 to a value above the dehydron threshold, thus
removing the local vulnerability created upon mutation and
reinforcing this HB. Addtionally, we will show that the molecule
PhiKan083 still leaves a flank of the CYS 220– THR 155 HB
unshielded from water. Thus, modifications of the small molecule
in order to also provide wrapping to such site would improve its
behavior. In fact, we have shown that such a modification further
stabilizes the HB and increases the binding free energy. In this
regard, after completion of this work we learnt on a very recent
development by the group pf Prof. Alan Fersht where they
generated new small molecules based on the knowledge gained
with PhiKan083 [17–19]. Precisely, a molecule that targets the
region we indicate here by means of an acetylene linker, not only
significantly increased the binding affinity as compared to
PhiKan083, but showed induction of apoptosis in a human cancer
cell line with homozygous Y220C mutation.
We hope the kind of analysis we present here that signals
relevant drug-protein binding interactions could be of help in
future efforts of drug design/(re)engineering.
Materials and Methods
We analyzed the wrapping of the protein T-p53C studied
experimentally by the group of Alan Fersht, both containing and
not containing the mutation Y220C. T-p53C is a superstable
version of p53 with wild-type-like properties, and the structure is
virtually identical to the wild-type apart from the mutated side
chains [2]. We also analyzed the wrapping of the Y220C mutated
protein in complex with the small molecule PhiKan083 and with
some drug-like fragments experimentally studied by the same
authors [2,7]. When we consider the T-p53C molecule, wrapping
to its different HBs would come from the side chains residues of its
own protein chain. In the cases of the complexes, additional
wrapping would come from the nonpolar moieties/groups of the
corresponding small-molecule ligand. To complete this description
it is necessary to classify pairwise electrostatic interactions, HBs, in
terms of an abundance distribution P(r), where r is the number of
three-body correlations associated with an interaction. Thus, the
extent of hydrogen-bond protection can be determined directly
from atomic coordinates (calculated directly from the pdb
structure of the protein or the protein-small molecule complex
of interest). This parameter indicates the number of three-body
correlations engaging the HB and is also known as the wrapping of
the bond [9–15] and denoted r.It is given by the number of
wrapper groups provided by the protein: the number of side-chain
carbonaceous nonpolar groups (CHn, n = 0, 1, 2, 3, where the
carbon atom of these groups is not bonded to an electrophilic atom
or polarized group) contained within a desolvation domain around
the HB. In turn, when we consider the complex between T-p53C
and PhiKan083 or some of the molecular fragments, we shall also
count the number of carbonaceous groups provided by the small
molecule. In any case, each wrapping nonpolar group represents
the third body within a three-body correlation involving the HB.
The desolvation domain considered is typically defined as the
reunion of two intersecting spheres of fixed radius (,thickness of
three water layers) centered at the a-carbons of the residues paired
by the hydrogen bond. In structures of pdb-reported soluble
proteins, HBs are protected on average by r= 26.667.5 side-
chain nonpolar groups for a desolvation sphere of radius 6 A˚ [9–
15]. Thus, structural deficiencies lie in the tail of the r-distribution,
i.e. their microenvironment contains 19 or fewer nonpolar groups,
so their r-value is below the mean ( = 26.6) minus one standard
deviation ( = 7.5). While the statistics on r-values for HB vary with
the radius, the tails of the distribution remain invariant, thus
enabling a robust identification of structural deficiencies [8–16].
Such underprotected interactions have been called dehydrons [8–
16], a structural motif which has been extensively discussed in the
literature and identified in soluble proteins with pdb-reported
structure [8–16]. As in [15], we only considered HBs and decided
to leave aside side chain - side chain HBs from the cooperativity
analysis based on the following grounds: The fluctuational nature
Table 1. Wrapping study of the T-p53C protein molecule
(pdb: 1UOL), the T-p53C-Y220C protein (pdb: 2J1X) and the
complex between p53C-Y220C and the small molecule
PhiKan083 (pdb: 2VUK).
HB rA-wt rA rAD
Arg 110– Trp 146 24 24 28
Leu 145– Thr 230 18 17 19
Tyr/Cys 220– Thr 155 23 18 20
The wrapping value of the HBs of the protein chain that occur at the mutation
site (mutation Y220C) and that are targeted by PhiKan083 is indicated
respectively as rA-wt, rA and rAD.
doi:10.1371/journal.pone.0055123.t001
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of surface side chains imposes an entropic cost associated with
hydrogen bond formation which makes the latter marginally stable
at best. Also, the wrapping statistics for side chain hydrogen bonds
are essentially flat with no clear distinction of the tails of the
distribution do to the conformational richness of the side chains.
We also performed Molecular Dynamics (MD) simulations of
a human p53 core domain mutant M133L-V203A-Y220C-
N239Y-N268D (T-p53C) (pdb ID = 2J1X) placed within a box
of 10182 TIP5P water molecules. We used the AMBER 11
molecular simulation suite [20] and the force field employed in the
simulation was ff99SB. We also simulated the p53 core domain
mutant Y220C bound to the stabilizing drug-like small-molecule
PhiKan083 (pdb ID = 2VUK) placed within a box of 10065
TIP5P water molecules. The force field used in the simulation was
ff99SB combined with GAFF. For the study of the complexes
between the T-p53C protein and modifications of the molecule
PhiKan083, we started from the original pdb 2VUK, we modified
the small molecule, generated the entry parameters by means of
ANTECHAMBER and solvated with the same number of TIP5P
water molecules (10065) also using ff99SB and GAFF. In all cases
we performed simulations at a temperature of T = 300 K, mean
pressure of 1 bar, and average density around 1.0 kg/dm3.
Equilibration was carried out in two steps: In a first step we
brought the system to the corresponding temperature value with
Figure 1. T-p53C-Y220C in complex with PhiKan083 (pdb: 2VUK). Dehydrons in the protein are depicted by green bars joining the two
residues paired by the HB, while green thin lines are wrapping interactions with the small molecule.
doi:10.1371/journal.pone.0055123.g001
Figure 2. Distribution of the distance between the C = O oxygen of THR 155 and the oxygen of the nearest water molecule. We show
this curve for pdb 2VUK (T-p53C-Y220C-PhiKan083; mean value of the distribution m= 3.102 A˚ and deviation s= 0.692 A˚) and 2J1X (T-p53C-Y220C;
m= 3.065 A˚ and s= 0.736 A˚). In both cases we used 2000 configurations and water was modeled with the TIP5P model.
doi:10.1371/journal.pone.0055123.g002
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a Langevin thermostat with 0.002 ps time step and using the
SHAKE algorithm; then we performed a larger equilibration
within the NpT ensemble, also using a Langevin thermostat with
0.002 ps time step and the SHAKE algorithm. All simulations
were done with AMBER 11 (PMEMD version 2.2 in GPU) and
were performed in the NpT ensemble with a Langevin thermostat
and by using a long-range-interaction cutoff of 8 A˚. Equilibration
was tested by monitoring the behavior of thermodynamical
properties like temperature, pressure, and energy oscillations.
The equilibration times were in each case much larger than the
structural relaxation time (ta, the time scale when the self-
intermediate scattering function evaluated at the first peak of the
structure factor has decayed to 1/e) for pure water at the
corresponding temperature. Production runs consisted in trajec-
tories of 2 ns. Three different replicas (different MD runs) were
employed in each case.
In turn, we also performed calculations of binding free energy
with AMBER by using the MM-GBSA program (Molecular
Mechanics/Generalized Born Surface Area [21,22]) with long
runs of at least 2 ns. Within this formalism, the value of the free
energy of binding (DGbind) of each compound was calculated
according to the equation:
DGbind~Gcom{Grec{Glig,
where com, rec, and lig stand for complex, receptor and ligand,
respectively. The free energy of each of these was estimated as
a sum of the following three terms:
G~vEMMwzvGpsolvwzvGnpsolvw,
where EMM is the molecular mechanics energy of the molecule
expressed as the sum of the internal energy of the molecule plus
the electrostatics and van der Waals interactions, Gpsolv is the polar
contribution to the solvation energy of the molecule, Gnpsolv is the
nonpolar solvation energy. We should keep in mind that the result
does not equal the real binding free energy since we did not
estimate the (dis-favourable) entropy contribution to binding.
Nevertheless this result could be used to compare similar systems.
The snapshots for MM-GBSA analyses were taken every 10 ps of
a 2000 ps MD production run, resulting in a total of two hundred
snapshots. In principle, the calculation of the binding free energy
described above would require three independent MD simulations
of the complex and both individual proteins. However, we use the
‘‘single trajectory approach’’ which makes the approximation that
no significant conformational changes occur upon binding so that
the snapshots for all three species can be obtained from a single
trajectory.
The energies were obtained using the mm_pbsa module of
Amber 11. The internal, electrostatics and van der Waals energies
were calculated with the sander module. The polar solvation free
energies (Gpsolv) were calculated by the generalized Born (GB)
approach [23,24] implemented in Amber 11. Finally, energy
estimations with GBSA were made with the Onufriev’s GB
parameters (igb = 2). All calculations used a solute internal
dielectric constant equal to 1 and a dielectric constant of 80 for
the exterior of the molecule. The nonpolar solvation term (Gnpsolv)
was calculated from the solvent-accessible surface area (SASA)
[25] using the equation:
Gnpsolv~dSASAzb,
where SASA was determined with the Molsurf [25] method using
a probe radius of 1.4 A˚. Parameters were d= 0.0072 kcal mol–
1 A˚–2 and b = 0 kcal mol–1 to be used with Amber PB or GB polar
solvation energies.
Results and Discussion
Table 1 shows the results of our wrapping analysis. The T-p53C
molecule is labeled as chain A-wt, the T-p53C with the oncogenic
mutation is denoted as chain A and the small-molecule
PhiKan083 is labeled as molecule D. Thus rA-wt would be the
wrapping contributed to the HBs of T-p53C by its own protein
chain A, rA will be the corresponding case for the molecule T-
p53C-Y220C (the version with the oncogenic mutation Y220C)
and rAD will be the wrapping of the HBs of T-p53C-Y220C
Figure 3. Distribution of the number of water molecules within the desolvation domain of the HB CYS 220 - THR 155. Pdbs 2VUK (T-
p53C-Y220C-PhiKan083; m= 8.743 and s= 1.720) and 2J1X (T-p53C-Y220C; m= 11.819 and s= 2.111).
doi:10.1371/journal.pone.0055123.g003
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within the complex with PhiKan083 (with wrapping contributions
both from the protein chain and the small molecule).
The first result that clearly transpires from this Table is the fact
that the mutation Y220C that creates a cavity at the protein
surface leads the wrapping value of the HB between TYR 220 and
THR 155 (well wrapped in T-p53C, with a rA-wt = 23) to below
the dehydron threshold (rA = 18 for the corresponding HB
between CYS 220 and THR 155 in T-p53C-Y220C). Thus, the
oncogenic mutation implies the creation of a dehydron in the
protein chain. Moreover, we can see that the HB between LEU
145 and THR 230 (vicinal to the mutation site and already
a dehydron in T-p53-Y220C) also lowers it wrapping content
upon mutation Y220C. The creation of a new vulnerability site (a
dehydron) and the overall wrapping content decrease should imply
a local destabilization [9,11] of the chain and an increase in local
disorder [13]. Thus, the effect of the oncogenic mutation that
destabilizes p53 can be accounted for in terms of the changes it
produces in wrapping interactions.
In turn, the binding of the small molecule PhiKan083 restores
function by stabilizing the p53 protein. From Table 1 we can
clearly see that the molecule binds to the protein precisely at the
dehydron sites by contributing wrapping to both dehydrons.
Moreover, the drug-like molecule restores the CYS 220– THR
155 HB to a wrapping value above the dehydron threshold, thus
removing the dehydron created upon the oncogenic mutation.
We have also studied the complexes between T-p53C and some
of the fragments probed experimentally by Fersht’s group [2] (for
example, the fragments termed as Fragment 15 and Fragment 2,
which were found to bind close to the position occupied by
PhiKan083 in the complex), and we found that they also tend to
contribute wrapping to the dehydron created upon the oncogenic
mutation (data not shown).
Fig. 1 shows the complex between T-p53C-Y220C and
PhiKan083 at the Y220C mutation. In the plot we indicate the
wrapping three-body interactions as lines that go from the
carbonaceous groups of the small molecule to the corresponding
HB of the protein. We can see that PhiKan083 provides wrapping
to the dehydron CYS 220– THR 155 from one side. In the study
of the group of Alan Fersht [2] they found that some fragments
(like Fragment 15) were placed a bit deeper within the cavity,
closer to the other side of such HB. They also found that
isopropanol molecules tend to place their carbonaceous groups
close to such region [2]. Thus, even when PhiKan083 raises the
wrapping level of the HB above the dehydron threshold, the HB
still presents a flank unshielded from water attack which is located
towards the other side or entrance of the cavity created upon
mutation. It seems reasonable to envision a modification of the
drug-like molecule by attaching to it a wrapper functional group at
such end in order to better protect this HB from the disrupting
effect of hydration. Additionally, another modification could
include a group that further increased the wrapping level of the
other dehydron of the protein at the cavity, the LEU 145– THR
230 HB.
In order to gain a better understanding of the destabilizing
nature of the oncogenic mutation Y220C and of the role of the
Figure 4. Time evolution of the distance between the backbone amide nitrogen atom of CYS 220 and the backbone carbonylic
oxygen of THR 155. Simulations form pdbs 2J1X (Fig. 4 a; m= 3.169 and s= 0.323) and 2VUK (Fig. 4 b; m= 3.165 and s= 0.254). A cutoff of 3.5 A˚ for
the hydrogen bond was chosen. We have also included (Fig. 4 c; m= 3.003 and s= 0.173) the case of molecule B (a modification of PhiKan083, please
see below) in complex with T-p53C-Y220C, as simulated form a starting configuration generated from a modification of pdb 2VUK. We mention that
this graph shows a single MD run for each case.
doi:10.1371/journal.pone.0055123.g004
Figure 5. An instance of intercalation of a water molecule between THR 155 and CYS 220 in 2J1X.
doi:10.1371/journal.pone.0055123.g005
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binding molecules we performed Molecular Dynamics (MD)
simulations.
Fig. 2 shows the distribution of the distance (d) between the
carbonylic oxygen of THR 155 and the nearest water molecule.
We recall that THR 155 forms a HB with CYS 220 in the mutated
T-p53C-Y220C (pdb 2J1X, free protein) and in the protein bound
to PhiKan083 (2VUK). In the second case we are dealing with
a well wrapped HB while in the first case this HB constitutes
a dehydron. From this picture it is evident that the water molecules
get a bit closer to the dehydron of the protein (free protein, 2J1X)
so as to attack the intramolecular interaction. In fact, the
corresponding peak is compatible with a water-protein hydrogen
bond formation when water acts as a donor [26].
Furthermore, in Fig. 3 we show the distribution of the number
of water molecules (nW) within the desolvation domain of the HB
CYS 220 - THR 155 (as already indicated, this domain is built as
a pair of spheres of radius 6 A˚, centered at the a carbons of both
residues involved in the HB). As expected, the dehydron CYS 220
- THR 155 in the free protein shows a higher water population
than the well-wrapped CYS 220– THR 155 HB in the
PhiKan083 bound protein.
In turn, Fig. 4 exhibits the time evolution of the distance
between the backbone amide nitrogen atom of CYS 220 and the
backbone carbonylic oxygen of THR 155 (dNO) along a simula-
tion (we considered 2000 configurations within a total simulation
time of 2 ns). We can observe that the fluctuations are clearly more
significant for the case of 2J1X protein (the free protein with the
oncogenic mutation). In fact, the HB breaks (surpasses the HB
distance threshold of 3.5 A˚) several times in the interval that goes
from 500 ps to 1000 ps (also take into account the s values in the
caption of Fig. 4). The dehydron creation upon mutation thus
promotes a local loosening in the protein chain since an
intermolecular interaction (the HB studied) gets destabilized with
temporal loss of local structural elements (the CYS 220– THR
155 HB represents an unstable intramolecular contact which is
easily disrupted by water). Thus, our results provide a further
support to the oncogenic nature of the Y220C mutation that
destabilizes the protein and lowers its melting temperature. In
some trajectories one can even find that at certain time a hydration
water molecule bridges the HB CYS 220– THR 155 interaction
(intercalating between both partners) and forming a couple of new
HBs: O–H-N with CYS 220 and C = O–H-O with THR 155.
This situation is illustrated in Fig. 5 and lasts many configurations
until the intramolecular HB is re-established.
On the other hand, in the presence of the molecule PhiKan083
(complex 2VUK), which provides wrapping to the dehydronic HB
CYS 220– THR 155, the N-O distance is a bit more stable during
the whole simulation, fluctuating more smoothly around a mean
value which is much lower than the HB threshold value. This fact
rationalizes the behavior of the small molecule which stabilizes the
protein and raises its melting temperature, thus restoring function.
It is also worth noting that the simulations show that the water
molecules approach the CYS 220– THR 155 dehydron from the
side of the protein cavity not occupied by PhiKan083. Thus, the
wrapping provided by such small molecule is very anisotropic.
Even when the HB increases its wrapping to a value above the
dehydron threshold (thus, the PhiKan083 molecule would remove
the dehydron if one merely considered the arithmetic r-value) it
lefts a flank completely unprotected at the other side of the cavity.
Water molecules could penetrate the cavity from such side and
attack the intramolecular HB. In fact, in Fig. 4 we can see that the
N-O distance of such HB indeed fluctuates and eventually slightly
surmounts the HB threshold value (3.5 A˚). In such figure we have
also included the case for our proposed modification of
PhiKan083 (molecule B, where that wrapping of the HB increases
even more than with PhiKan083, please see below), which indeed
performs much better. It is worth noting that the standard
deviation for the distributions falls as the wrapping of the HB
increases, that is, as we go from Fig. 4a. to Fig. 4c.
To make this observation more precise, In Fig. 6 we show the
distribution of the CYS 220– THR 155 N-O distance (dNO)
during the simulation. We show the results for the free protein
molecule and the case for the complex with PhiKan083. Again,
this graph shows that the small molecule makes the HB more
Figure 6. Distribution for the distance between the amidic N atom and the carbonylic O atom. HBs with r.19 (well wrapped) in 2J1X
(m= 2.949 and s= 0.276), HBs with r#19 (poorly wrapped) in 2J1X (m= 3.208 and s= 0.564), CYS 220– THR 155 in 2VUK (m= 3.150 and s= 0.288) and
CYS 220– THR 155 in 2J1X (m= 3.143 and s= 0.339). Attention should be paid to the tails of the distributions, that is, at large values of the N-O
distance. These data come from the study of the three replicas for each case.
doi:10.1371/journal.pone.0055123.g006
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stable by shortening the distance for the HB partners (please see
the tails of the distributions, that is, the behavior at large values of
the N-O distance which shows that the curve for the complex with
PhiKan083, 2VUK, decays earlier than that for the free protein,
2J1X). In such graph we have also included the average behavior
of the different HBs of the protein, both dehydrons (r#19) and
non-dehydrons or well wrapped HBs (r.19). We can easily see
that the dehydrons present a large tail in the range above the HB
threshold value while the curve for the well-wrapped HBs decays
much earlier. Thus, the CYS 220– THR 155 HB of the complex
between PhiKan083 and the protein displays a behavior that is
somehow intermediate between these two limit cases. This
reinforces the idea that the protection provided by the small
molecule is only partial given the fact that it leaves a flank
unshielded. Again, from Fig. 6 we can learn that the standard
deviation of the distributions falls as the wrapping of the HB
increases.
These facts point to the possibility of a rational redesign or
improvement of the small molecule PhiKan083. Thus, we
proposed to modify such small molecule by attaching some
wrapper functional groups that might improve the wrapping
protection of the CYS 220– THR 155 HB (see Fig. 7). Thus, the
new small molecule would also reach the other side of the cavity.
From the results of the free energy of binding (please see later on
for the details of the calculations) we chose the second modification
(case B, the molecule which provides the better shielding from
water) for further studies. Thus, by replacing the PhiKan083 by
this molecule (case B) within the 2VUK pdb, we performed new
MD simulations with AMBER.
Figure 8 shows the improvement this new molecule produces in
the CYS 220– THR 155 HB distance. The new molecule, which
better wraps the HB, indeed yields a distribution very similar to
the one corresponding to well wrapped HBs of 2J1X, thus making
the HB even much more stable than PhiKan083 (lower mean
Figure 7. Molecular structure and of Phikan083 and modifications. The mean value we calculate for the binding free energy of the complex
T-p53C-Y220C-PhiKan083 (2VUK) is ,DGbinding.=229.42 kcal/mol (Standard deviation, STD = 2.05 kcal/mol). A) First modification of Phikan083.
,DGbinding.=229.80 kcal/mol (STD = 2.71 kcal/mol). B) Second modification of Phikan083. ,DGbinding.=235.33 kcal/mol (STD = 2.81 kcal/mol).
doi:10.1371/journal.pone.0055123.g007
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value and deviation). This strengthening of the CYS 220– THR
155 HB is also evident in Fig. 4c which tells us that, at variance
from the situation in the free protein or in the case of the complex
with PhiKan083, the N–O distance remains practically all the
simulation time below the HB threshold value. Additionally, in
Fig. 9 we show a plot of the number of water molecules within the
desolvation domain of CYS 220– THR 155 HB. We show the
case for the free oncogenic T-p53C-Y220C, for the complex with
PhiKan083 and for the complex with the new molecule (molecule
B in Fig. 7).
In turn, we performed a calculation of the binding free energy
with AMBER by using the MM-GBSA program (Molecular
Mechanics/Generalized Born Surface Area). Our results are
displayed in Fig. 10. We can see that the new molecule produces
a greater DG of binding to T-p53C-Y220C. While the mean value
for PhiKan083 is roughly 29 Kcal/mol, the modified molecule
yields a value of around 35 Kcal/mol. Thus, these results point to
the feasibility of an improvement of lead compounds by
considering the wrapping interactions. In the modified PhiKan083
case, the protein structure is strengthened by tying or fastening the
HB responsible for the oncogenic mutation, given the fact that this
intramolecular interaction is now well shielded from water attack.
Finally, Figure 11 illustrates the wrapping interactions in the
complexes of T-p53C-Y220C with the second modification of
PhiKan083 (molecule B in Fig.7). The modified small-molecule
penetrates deeper into the cavity thus providing a better shielding
from water to the CYS 220– THR 155 HB and forms an
additional HB with PRO 151. Interestingly, the study of Fersht’s
Figure 8. Distribution of the distance between the N atom of the amide group and the O atom of the carbonyl. HBs with r.19 in 2J1X
(m= 2.949 and s= 0.276), CYS 220– THR 155 in 2VUK (m= 3.150 and s= 0.288) and CYS 220– THR 155 in the second modification of Phikan083
(molecule B in Fig. 7; m= 3.000 and s= 0.235).
doi:10.1371/journal.pone.0055123.g008
Figure 9. Distribution of the number of water molecules within the desolvation domain of the HB CYS 220– THR 155. 2J1X (m= 11.819
and s= 2.111), 2VUK (m= 8.743 and s= 1.720) and CYS 220– THR 155 in the second modification of Phikan083 (molecule B, m= 7.847 and s= 1.573).
doi:10.1371/journal.pone.0055123.g009
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group found an enhanced isopropanol density around this latter
place when simulating the protein in a mixture of water-
isopropanol. Additionally, after our work was finished we learnt
that in a very recent work this group developed new small
molecules which extended the region targeted by PhiKan083 in
both extremes [17]. Precisely, only the extension of the lead
molecule to target the region we indicate here by means of an
acetylene linker provided a significantly increased binding affinity
to the low mM range and a substantial stabilization of the protein
as compared to PhiKan083. Such small molecules, called
PhiKan5174 and PhiKan5196, also produced induction of
apoptosis in a human cancer cell line with homozygous Y220C
mutation. In addition, these compounds have been used to
highlight the fact that p53-Y220C aggregation is modified
significantly [18,19].
Conclusion
In summary, our study has revealed that the oncogenic Y220C
mutation that lowers the stability of the tumor suppressor protein
p53 can be explained by the reduction it produces in the wrapping
content at the mutation site and, more significantly, by the
creation of a net structural vulnerability, a dehydron. This
mutation locally loosens the protein structure since the dehydronic
CYS 220– THR 155 HB is now accessible by water and wildly
fluctuates, breaking and reforming in the course of time, thus
promoting the structural destabilization. The binding of drug-like
Figure 10. Time evolution for the binding free energy (DGbinding) during a simulation run. Black line: T-p53C-Y220C-PhiKan083; gray line:
2nd modification of PhiKan083 (B) – T-p53C-Y220C; dotted black line: mean value for T-p53C-Y220C-PhiKan083; dotted gray line: mean value for the
2nd modification of PhiKan083 (B) – T-p53C-Y220C.
doi:10.1371/journal.pone.0055123.g010
Figure 11. Illustration of the wrapping interactions between T-p53C-Y220C and the second modification of PhiKan083 (molecule B
in Fig.7).
doi:10.1371/journal.pone.0055123.g011
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small molecules intended to rescue the function of p53 can be
explained precisely by the wrapping such molecules contribute to
the mutation site. We show that the small molecule in fact removes
the dehydron created upon the oncogenic mutation. Thus, such
molecules tighten the CYS 220– THR 155 HB and locally
stabilize the protein structure. However, some function-rescue
molecules (like PhiKan083) only provide wrapping from one side
of the cavity where such HB is placed, entirely leaving the other
flank unshielded. Thus, we have shown that a modification of such
molecule better wraps the HB and further strengthens the protein
chain at the local site. We also show computationally that such
a modified molecule presents an increased binding free energy as
compared with PhiKan083. We expect this knowledge could be
instrumental in the re-engineering of such kind of molecules to
gain a better affinity, in the rational design of new drugs for this
case, and also to help in other cases of drug design/(re)engineer-
ing.
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